Generation of Human Cardiomyocytes: A Differentiation Protocol from Feeder-free Human Induced Pluripotent Stem Cells

Journal of Visualized Experiments

Volumn , Issue 76, 2013, Pages

  Pasquale, Elisa Di ^a,b   Song, Belle ^a   Condorelli, Gianluigi ^a  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b Milan Unit   (Italy)

Author keywords

Bioengineering; Biomedical engineering; Cardiac differentiation; Cardiology; Cardiovascular diseases; Cell cultur; Cell lines; Cellular biology; Developmental biology; Disease modeling; Embryoid bodies; Genetics; Human cardiomyocytes; Induced pluripotent stem cells; Ips cells; Issue 76; Medicine; Molecular biology; Stem cell biology; Stem cell research; Stem cells

Indexed keywords

EID: 84879665292     PISSN: 1940087X     EISSN: None     Source Type: Journal    
DOI: 10.3791/50429     Document Type: Article

References (21)

1. Di Pasquale, E., Latronico, M.V., Jotti, G.S., & Condorelli, G. Lentiviral vectors and cardiovascular diseases: a genetic tool for manipulating cardiomyocyte differentiation and function. Gene Therapy. 19, 642-648, doi:10.1038/gt.2012.19 (2012).
2. Laflamme, M.A. & Murry, C.E. Heart regeneration. Nature. 473, 326-335, doi:10.1038/nature10147 (2011).
3. Mummery, C.L., et al. Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview. Circulation Research. 111, 344-358, doi:10.1161/CIRCRESAHA.110.227512 (2012).
4. Wu, S.M., Chien, K.R., & Mummery, C. Origins and fates of cardiovascular progenitor cells. Cell. 132, 537-543 (2008).
5. Thomson, J.A., et al. Embryonic stem cell lines derived from human blastocysts. Science. 282, 1145-1147 (1998).
6. Takahashi, K., et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 131, 861-872 (2007).
7. Yu, J., et al. Induced pluripotent stem cell lines derived from human somatic cells. Science. 318, 1917-1920, doi:10.1126/science.1151526 (2007).
8. Yamanaka, S. A fresh look at iPS cells. Cell. 137, 13-17 (2009).
9. Josowitz, R., Carvajal-Vergara, X., Lemischka, I.R., & Gelb, B.D. Induced pluripotent stem cell-derived cardiomyocytes as models for genetic cardiovascular disorders. Curr. Opin. Cardiol. 26, 223-229, doi:10.1097/HCO.0b013e32834598ad (2011).
10. Park, I.H., et al. Disease-specific induced pluripotent stem cells. Cell. 134, 877-886, doi:10.1016/j.cell.2008.07.041 (2008).
11. Carvajal-Vergara, X., et al. Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome. Nature. 465, 808-812, doi:10.1038/nature09005 (2012).
12. Moretti, A., et al. Patient-specific induced pluripotent stem-cell models for long-QT syndrome. N. Engl. J. Med. 363, 1397-1409, doi:10.1056/NEJMoa0908679 (2010).
13. Yazawa, M., et al. Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome. Nature. 471, 230-234, doi:10.1038/nature09855 (2011).
14. Itzhaki, I., et al. Modeling of catecholaminergic polymorphic ventricular tachycardia with patient-specific human-induced pluripotent stem cells. Journal of the American College of Cardiology. 60, 990-1000, doi:10.1016/j.jacc.2012.02.066 (2012).
15. Jung, C.B., et al. Dantrolene rescues arrhythmogenic RYR2 defect in a patient-specific stem cell model of catecholaminergic polymorphic ventricular tachycardia. EMBO Molecular Medicine. 4, 180-191, doi:10.1002/emmm.201100194 (2012).
16. Sun, N., et al. Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy. Science Translational Medicine. 4, 130ra147, doi:10.1126/scitranslmed.3003552 (2012).
17. Kehat, I., et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. The Journal of Clinical Investigation. 108, 407-414, doi:10.1172/JCI12131 (2001).
18. Cao, N., et al. Ascorbic acid enhances the cardiac differentiation of induced pluripotent stem cells through promoting the proliferation of cardiac progenitor cells. Cell Research. 22, 219-236, doi:10.1038/cr.2011.195 (2012).
19. Takahashi, T., et al. Ascorbic acid enhances differentiation of embryonic stem cells into cardiac myocytes. Circulation. 107, 1912-1916, doi:10.1161/01.CIR.0000064899.53876.A3 (2003).
20. Moretti, A., et al. Patient-specific induced pluripotent stem-cell models for long-QT syndrome. N. Engl. J. Med. 363, 1397-1409, doi:10.1056/NEJMoa0908679 (2011).
21. Watanabe, K., et al. A ROCK inhibitor permits survival of dissociated human embryonic stem cells. Nature Biotechnology. 25, 681-686, doi:10.1038/nbt1310 (2007).